Intravenous immunoglobulins: an eye opener on the successful treatment of severe adult-onset paraprotein-associated xanthogranulomatosis

Clin Exp Dermatol. 2021 Oct;46(7):1346-1348. doi: 10.1111/ced.14727. Epub 2021 Jun 15.

Authors

C Bergqvist^{1

2}, C Bernigaud^{1

2}, S Ingen-Housz-Oro¹, P Sujobert³, C Hotz¹, C Lebre¹, N Ortonne^{4

2}, O Chosidow^{1

2}

Affiliations

¹ Departments of, Department of, Dermatology, AP-HP, Henri Mondor Jospital, Créteil, France.
² Université Paris-Est Créteil, Créteil, France.
³ Department of Biological Haematology, Hôpital Lyon-sud, Pierre-Bénite, France.
⁴ Department of, Pathology, AP-HP, Henri Mondor Jospital, Créteil, France.

PMID: 33969535
DOI: 10.1111/ced.14727

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Humans
Immunoglobulins, Intravenous / therapeutic use*
Male
Middle Aged
Paraproteins
Skin / pathology*
Xanthomatosis / pathology
Xanthomatosis / therapy*

Substances

Immunoglobulins, Intravenous
Paraproteins